Eugia Pharma receives USFDA Approval for Leuprolide Acetate Injection
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
Subscribe To Our Newsletter & Stay Updated